Elsevier

JAAD Case Reports

Volume 3, Issue 3, May 2017, Pages 230-232
JAAD Case Reports

Case report
Peritoneal tuberculosis in the setting of ustekinumab treatment for psoriasis

https://doi.org/10.1016/j.jdcr.2017.02.001Get rights and content
Under a Creative Commons license
open access

Key words

peritoneal tuberculosis
psoriasis
psoriatic arthritis
ustekinumab

Abbreviations used

IL
interleukin
MDR
multidrug resistant
PsA
psoriatic arthritis
TB
tuberculosis
TNF
tumor necrosis factor

Cited by (0)

Funding sources: None.

Conflicts of interest: Maeve Lynch has received a research grant from Merck & Co. and has acted as an advisory board member for Novartis. The rest of the authors have no conflicts of interest to declare.